Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2002 June;46(2) > The Quarterly Journal of Nuclear Medicine 2002 June;46(2):145-51

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

REVIEW ARTICLES  THE REPRODUCTIVE SYSTEM
Guest Editors: Freeman L. M., Bombardieri E.


The Quarterly Journal of Nuclear Medicine 2002 June;46(2):145-51

lingua: Inglese

Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects

De Cicco C., Pizzamiglio M., Trifirò G., Luini A., Ferrari M., Prisco G., Galimberti V., Cassano E., Viale G., Intra M., Veronesi P., Paganelli G.

Nuclear Med­i­cine, Radiology, ­Senology and ­Pathology Divi­sions Euro­pean Insti­tute of ­Oncology, ­Milan, ­Italy


FULL TEXT  


Back­ground. The sur­gical man­age­ment of non-pal­pable ­breast ­lesions ­remains con­tro­ver­sial. At our Insti­tute we ­have intro­duced a new tech­nique, radio­guided ­occult ­lesion local­isa­tion (­ROLL) to ­replace stan­dard ­methods and over­come ­their dis­ad­van­tages. In ­this ­paper tech­nical ­aspects of ­ROLL and ­results on a ­large ­series of ­patients are ­reported.
­Methods. We ana­lysed 812 con­sec­u­tive ­patients ­with 816 non-pal­pable ­breast ­lesions ­detected mam­mo­graph­i­cally or ultra­son­i­cally. 99mTc-­labelled par­ti­cles of ­human ­serum ­albumin (7-10 MBq) in 0.2 ml ­saline ­were ­injected ­into the ­lesion ­under ster­eo­tactic mam­mo­graphic or ultra­sonic guid­ance. Mam­mog­raphy and scin­tig­raphy ­were ­then per­formed. ­With ultra­sound guid­ance ­only scin­ti­graphic con­trol was nec­es­sary. The exci­sion ­biopsy was car­ried out ­with the aid of a ­hand-­held γ-­detecting ­probe, and ­entire ­removal of the ­lesion was ver­i­fied by X-ray of the spec­imen.
­Results. The ­tracer was cor­rectly posi­tioned ­initially in 772/816 (94.6%) ­cases and at ­second ­attempt in ­another 2. In 42/816 (5.1%) ­cases, ­lesion local­isa­tion had to be ­repeated ­using a tra­di­tional ­approach. X-ray dem­on­strated the ­lesion was ­entirely ­removed in 770/774 (99.5%) ­cases. Path­o­log­ical exam­ina­tion ­revealed 367 (47.4%) ­benign ­lesions and 407 (52.6%) can­cers. The can­cers ­were ­treated by con­ser­va­tive ­breast sur­gery in 99.5% of ­cases.
Con­clu­sions. We con­cluded ­that ­ROLL ­enables the sur­geon to ­remove ­occult ­breast ­lesions ­easily and reli­ably.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail